Paraneoplastic cerebellar degeneration (PCD)

What is paraneoplastic cerebellar degeneration (PCD)? 

Paraneoplastic cerebellar degeneration is the most common remote effect of neoplasm affecting the brain, associated with lung (especially small-cell), ovarian, and breast neoplasms as well as Hodgkin’s disease.

A prodrome (a viral-like illness, dizziness, nausea, or vomiting) may be followed by rapid development and progression of gait unsteadiness, ataxia, diplopia, dysarthria, and dysphagia over a few weeks to months.

Pathology reveals extensive loss of Purkinje cells and inflammatory infiltrates.

Neuroimaging is typically normal early, with delayed progressive cerebellar atrophy.

Associated antibodies include (1) anti-Hu or ANNA1 (found predominantly in small-cell lung cancer); (2) anti-Yo or PCA1 (ovarian and breast cancers); and (3) anti-Tr (Hodgkin’s lymphoma).

Treatment includes steroids, plasmapheresis, intravenous immunoglobulin, tacrolimus, and rituximab, with varying success, or complete removal of the underlying malignancy.


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top